Rockwell Medical, Inc.
RMTI
$1.47
$0.2318.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.79% | 12.82% | 21.38% | 22.37% | 24.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.79% | 12.82% | 21.38% | 22.37% | 24.58% |
| Cost of Revenue | -11.18% | 3.63% | 12.14% | 13.12% | 18.38% |
| Gross Profit | 21.51% | 90.45% | 100.87% | 104.59% | 87.97% |
| SG&A Expenses | 10.64% | 13.43% | 18.15% | 5.20% | -4.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.42% | 4.26% | 11.74% | 10.59% | 13.58% |
| Operating Income | 58.23% | 108.71% | 109.12% | 107.17% | 69.25% |
| Income Before Tax | 56.01% | 96.86% | 94.31% | 86.69% | 58.89% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 56.01% | 96.86% | 94.31% | 86.69% | 58.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 56.01% | 96.86% | 94.31% | 86.69% | 58.89% |
| EBIT | 58.23% | 108.71% | 109.12% | 107.17% | 69.25% |
| EBITDA | 201.24% | 157.96% | 153.35% | 139.30% | 90.62% |
| EPS Basic | 55.64% | 94.60% | 92.38% | 89.78% | 81.29% |
| Normalized Basic EPS | 65.76% | 98.10% | 95.66% | 91.41% | 80.63% |
| EPS Diluted | 51.03% | 92.68% | 90.81% | 88.72% | 80.94% |
| Normalized Diluted EPS | 65.06% | 97.61% | 95.25% | 91.10% | 80.58% |
| Average Basic Shares Outstanding | 14.57% | 26.09% | 45.24% | 75.36% | 125.47% |
| Average Diluted Shares Outstanding | 13.77% | 28.49% | 48.10% | 78.95% | 128.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |